{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:59:01Z","timestamp":1783479541560,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81374008"],"award-info":[{"award-number":["81374008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.intimp.2016.02.009","type":"journal-article","created":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T19:30:20Z","timestamp":1455996620000},"page":"119-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-\u03baB pathways"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1755-9404","authenticated-orcid":false,"given":"Chonghua","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meili","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingsheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2016.02.009_bb0005","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1139\/y84-061","article-title":"Development of isoproterenol-induced cardiac hypertrophy","volume":"62","author":"Taylor","year":"1984","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.intimp.2016.02.009_bb0010","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.RES.65.3.657","article-title":"Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis","volume":"65","author":"Benjamin","year":"1989","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2016.02.009_bb0015","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1476-5381.2010.01043.x","article-title":"Myocardial oxidative stress contributes to transgenic beta(2)-adrenoceptor activation-induced cardiomyopathy and heart failure","volume":"162","author":"Xu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2016.02.009_bb0020","doi-asserted-by":"crossref","first-page":"e91877","DOI":"10.1371\/journal.pone.0091877","article-title":"Isoproterenol induces vascular oxidative stress and endothelial dysfunction via a Gialpha-coupled beta2-adrenoceptor signaling pathway","volume":"9","author":"Davel","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2016.02.009_bb0025","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bjp.0706749","article-title":"Changes in vascular reactivity following administration of isoproterenol for 1week: a role for endothelial modulation","volume":"148","author":"Davel","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2016.02.009_bb0030","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1152\/ajpregu.00323.2002","article-title":"Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase","volume":"284","author":"Fleming","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.intimp.2016.02.009_bb0035","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.CIR.100.3.292","article-title":"Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production","volume":"100","author":"Bauersachs","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2016.02.009_bb0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00004872-200202000-00018","article-title":"Irbesartan lowers superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone rats","volume":"20","author":"Brosnan","year":"2002","journal-title":"J. Hypertens."},{"key":"10.1016\/j.intimp.2016.02.009_bb0045","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8","article-title":"Nitric oxide in the pathogenesis of vascular disease","volume":"190","author":"Li","year":"2000","journal-title":"J. Pathol."},{"key":"10.1016\/j.intimp.2016.02.009_bb0050","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1172\/JCI200314172","article-title":"Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension","volume":"111","author":"Landmesser","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2016.02.009_bb0055","doi-asserted-by":"crossref","first-page":"H1530","DOI":"10.1152\/ajpheart.00823.2007","article-title":"Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS","volume":"294","author":"Crabtree","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.intimp.2016.02.009_bb0060","doi-asserted-by":"crossref","first-page":"25804","DOI":"10.1074\/jbc.273.40.25804","article-title":"Superoxide generation from endothelial nitric-oxide synthase. A Ca2+\/calmodulin-dependent and tetrahydrobiopterin regulatory process","volume":"273","author":"Xia","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2016.02.009_bb0065","doi-asserted-by":"crossref","first-page":"H211","DOI":"10.1152\/ajpheart.00581.2007","article-title":"Effects of isoproterenol treatment for 7days on inflammatory mediators in the rat aorta","volume":"295","author":"Davel","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.intimp.2016.02.009_bb0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1476-5381.2010.01196.x","article-title":"Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling","volume":"164","author":"Forstermann","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2016.02.009_bb0075","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.105.602532","article-title":"Endothelial nitric oxide synthase in vascular disease: from marvel to menace","volume":"113","author":"Forstermann","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2016.02.009_bb0080","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1042\/bj3620733","article-title":"The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study","volume":"362","author":"Vasquez-Vivar","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.intimp.2016.02.009_bb0085","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.tcm.2004.10.003","article-title":"Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease","volume":"14","author":"Channon","year":"2004","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.intimp.2016.02.009_bb0090","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.ATV.0000110785.96039.f6","article-title":"Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease","volume":"24","author":"Alp","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2016.02.009_bb0095","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1074\/jbc.M805403200","article-title":"Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression","volume":"284","author":"Crabtree","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2016.02.009_bb0100","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.freeradbiomed.2009.07.024","article-title":"Tetrahydrobiopterin, superoxide, and vascular dysfunction","volume":"47","author":"Vasquez-Vivar","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2016.02.009_bb0105","doi-asserted-by":"crossref","first-page":"27540","DOI":"10.1074\/jbc.M114.604231","article-title":"Inflammatory monocytes determine endothelial nitric-oxide synthase uncoupling and nitro-oxidative stress induced by angiotensin II","volume":"289","author":"Kossmann","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2016.02.009_bb0110","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI21968","article-title":"Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load","volume":"115","author":"Takimoto","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2016.02.009_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2013.10.017","article-title":"Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4\/NF-small ka, CyrillicB signaling pathway in isoproterenol-induced myocardial hypertrophy","author":"Yang","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2016.02.009_bb0120","first-page":"63","article-title":"Astragaloside IV protects against cardiac hypertrophy via inhibiting the Ca2+\/CaN signaling pathway","volume":"80","author":"Lu","year":"2014","journal-title":"Planta Med."},{"key":"10.1016\/j.intimp.2016.02.009_bb0125","doi-asserted-by":"crossref","first-page":"e0118759","DOI":"10.1371\/journal.pone.0118759","article-title":"Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-kappaB\/PGC-1alpha signaling mediated energy biosynthesis","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2016.02.009_bb0130","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ptr.5297","article-title":"Astragaloside IV attenuates injury caused by myocardial ischemia\/reperfusion in rats via regulation of toll-like receptor 4\/nuclear factor-kappaB signaling pathway","volume":"29","author":"Lu","year":"2015","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2016.02.009_bb0135","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1440-1681.2007.04564.x","article-title":"Mechanisms underlying vasorelaxant action of astragaloside IV in isolated rat aortic rings","volume":"34","author":"Zhang","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.intimp.2016.02.009_bb0140","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.jacc.2006.01.071","article-title":"Reversal of endothelial nitric oxide synthase uncoupling and up-regulation of endothelial nitric oxide synthase expression lowers blood pressure in hypertensive rats","volume":"47","author":"Li","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.intimp.2016.02.009_bb0145","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pnpbp.2008.12.020","article-title":"Evaluation of the effects of vitamin A supplementation on adult rat substantia nigra and striatum redox and bioenergetic states: mitochondrial impairment, increased 3-nitrotyrosine and alpha-synuclein, but decreased D2 receptor contents","volume":"33","author":"de Oliveira","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.intimp.2016.02.009_bb0150","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1161\/STROKEAHA.114.006135","article-title":"Ischemic postconditioning relieves cerebral ischemia and reperfusion injury through activating T-LAK cell-originated protein kinase\/protein kinase B pathway in rats","volume":"45","author":"Zhao","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.intimp.2016.02.009_bb0155","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cca.2006.11.014","article-title":"Establishment of a sandwich ELISA using commercial antibody for plasma or serum 3-nitrotyrosine (3NT). Elevation in inflammatory diseases and complementary between 3NT and myeloperoxidase","volume":"378","author":"Sun","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.intimp.2016.02.009_bb0160","doi-asserted-by":"crossref","first-page":"H225","DOI":"10.1152\/ajpheart.00548.2003","article-title":"Hypertension alters role of iNOS, COX-2, and oxidative stress in bradykinin relaxation impairment after LPS in rat cerebral arteries","volume":"287","author":"Hernanz","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.intimp.2016.02.009_bb0165","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1161\/01.CIR.0000012748.58444.08","article-title":"Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase","volume":"105","author":"Guzik","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2016.02.009_bb0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1124\/jpet.109.159863","article-title":"20-Hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling","volume":"332","author":"Cheng","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2016.02.009_bb0175","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1073\/pnas.95.16.9220","article-title":"Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors","volume":"95","author":"Vasquez-Vivar","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2016.02.009_bb0180","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/jnc.12824","article-title":"Erythropoietin increases bioavailability of tetrahydrobiopterin and protects cerebral microvasculature against oxidative stress induced by eNOS uncoupling","volume":"131","author":"Santhanam","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2016.02.009_bb0185","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/bbrc.1997.7069","article-title":"Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase","volume":"237","author":"Wever","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2016.02.009_bb0190","first-page":"503","article-title":"Nitric oxide as a unique signaling molecule in the vascular system: a historical overview","volume":"53","author":"Ignarro","year":"2002","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.intimp.2016.02.009_bb0195","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/cvr\/cvp099","article-title":"K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function","volume":"83","author":"Gao","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.intimp.2016.02.009_bb0200","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/art.21891","article-title":"Endothelial dysfunction in rat adjuvant-induced arthritis: vascular superoxide production by NAD(P)H oxidase and uncoupled endothelial nitric oxide synthase","volume":"54","author":"Haruna","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2016.02.009_bb0205","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1161\/01.ATV.21.6.1017","article-title":"Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice","volume":"21","author":"d'Uscio","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2016.02.009_bb0210","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1089-8603(02)00111-8","article-title":"Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs","volume":"7","author":"Li","year":"2002","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.intimp.2016.02.009_bb0215","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1172\/JCI0214442","article-title":"Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite","volume":"109","author":"Zou","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2016.02.009_bb0220","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1172\/JCI0215215","article-title":"Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice","volume":"110","author":"Ozaki","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2016.02.009_bb0225","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/01.RES.72.2.403","article-title":"Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium","volume":"72","author":"Ma","year":"1993","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2016.02.009_bb0230","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1055\/s-2006-931572","article-title":"Astragaloside IV dilates aortic vessels from normal and spontaneously hypertensive rats through endothelium-dependent and endothelium-independent ways","volume":"72","author":"Zhang","year":"2006","journal-title":"Planta Med."},{"key":"10.1016\/j.intimp.2016.02.009_bb0235","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.3390\/molecules16053896","article-title":"Astragaloside IV improves metabolic syndrome and endothelium dysfunction in fructose-fed rats","volume":"16","author":"Zhang","year":"2011","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.intimp.2016.02.009_bb0240","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1248\/bpb.33.641","article-title":"Astragaloside IV improves homocysteine-induced acute phase endothelial dysfunction via antioxidation","volume":"33","author":"Qiu","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.intimp.2016.02.009_bb0245","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1161\/CIRCULATIONAHA.107.737031","article-title":"Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy","volume":"117","author":"Moens","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2016.02.009_bb0250","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0008-6363(03)00390-0","article-title":"Tetrahydrobiopterin and antioxidants reverse the coronary endothelial dysfunction associated with left ventricular hypertrophy in a porcine model","volume":"59","author":"Malo","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.intimp.2016.02.009_bb0255","doi-asserted-by":"crossref","first-page":"E481","DOI":"10.1152\/ajpendo.00540.2011","article-title":"Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities","volume":"302","author":"Kietadisorn","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2016.02.009_bb0260","doi-asserted-by":"crossref","first-page":"e1004667","DOI":"10.1371\/journal.ppat.1004667","article-title":"Impaired systemic tetrahydrobiopterin bioavailability and increased dihydrobiopterin in adult falciparum malaria: association with disease severity, impaired microvascular function and increased endothelial activation","volume":"11","author":"Yeo","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2016.02.009_bb0265","first-page":"499","article-title":"Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion","volume":"68","author":"Collins","year":"1993","journal-title":"Lab. Investig."},{"key":"10.1016\/j.intimp.2016.02.009_bb0270","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1128\/MCB.26.1.140-154.2006","article-title":"Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes","volume":"26","author":"Li","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.intimp.2016.02.009_bb0275","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1160\/TH03-03-0136","article-title":"Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression","volume":"90","author":"Zhang","year":"2003","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.intimp.2016.02.009_bb0280","doi-asserted-by":"crossref","first-page":"359732","DOI":"10.1155\/2010\/359732","article-title":"Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity","volume":"2010","author":"Ndisang","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.intimp.2016.02.009_bb0285","doi-asserted-by":"crossref","first-page":"H1016","DOI":"10.1152\/ajpheart.00779.2004","article-title":"Cytokines and vascular reactivity in resistance arteries","volume":"288","author":"Vila","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.intimp.2016.02.009_bb0290","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/01.CCM.0000120049.43113.90","article-title":"Protecting the myocardium: a role for the beta2 adrenergic receptor in the heart","volume":"32","author":"Patterson","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.intimp.2016.02.009_bb0295","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cca.2003.10.011","article-title":"Chronic oral administration of raw garlic protects against isoproterenol-induced myocardial necrosis in rat","volume":"136","author":"Banerjee","year":"2003","journal-title":"Comp. Biochem. Physiol. Toxicol. Pharmacol."},{"key":"10.1016\/j.intimp.2016.02.009_bb0300","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.yjmcc.2011.09.022","article-title":"Beta2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo","volume":"52","author":"Murray","year":"2012","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916300443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916300443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T16:56:13Z","timestamp":1567616173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576916300443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":60,"alternative-id":["S1567576916300443"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2016.02.009","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-\u03baB pathways","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2016.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}